Saranac Partners’s Universal Health Services UHS Stock Holding History

Saranac Partners’s Portfolio UHS Stock Details UHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-810	Closed	-$166K	–	143
2025 Q3	$166K	Buy	+810	New	+$146K	0.03%	210

Other funds holding UHS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Saranac Partners's UHS Position: Q4 2025 in Review

Saranac Partners sold out of Universal Health Services (UHS) in Q4 2025, closing a stake of 810 shares — an estimated $166K sold.

Saranac Partners first reported a position in UHS in Q3 2025 and held it in 1 quarter. The position peaked at $166K in Q3 2025. 687 funds tracked by Wall St. Rank hold UHS as of Q4 2025.

Saranac Partners reported no remaining Universal Health Services position as of Q4 2025 after selling out during the quarter.
Saranac Partners sold 810 Universal Health Services shares in Q4 2025, an estimated $166K.
Saranac Partners first reported a position in Universal Health Services in Q3 2025 and held it in 1 quarter.
Saranac Partners's Universal Health Services position peaked at $166K in Q3 2025.
687 funds tracked by Wall St. Rank held Universal Health Services as of Q4 2025.

Based on Saranac Partners's 13F filing for Q4 2025, filed 6 Feb 2026.